Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.

Standard

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. / Heimpel, Hermann; Anselstetter, Volker; Chrobak, Ladislav; Denecke, Jonas; Einsiedler, Beate; Gallmeier, Kerstin; Griesshammer, Antje; Marquardt, Thorsten; Janka-Schaub, Gritta; Kron, Martina; Kohne, Elisabeth.

in: BLOOD, Jahrgang 102, Nr. 13, 13, 2003, S. 4576-4581.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Heimpel, H, Anselstetter, V, Chrobak, L, Denecke, J, Einsiedler, B, Gallmeier, K, Griesshammer, A, Marquardt, T, Janka-Schaub, G, Kron, M & Kohne, E 2003, 'Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.', BLOOD, Jg. 102, Nr. 13, 13, S. 4576-4581. <http://www.ncbi.nlm.nih.gov/pubmed/12933587?dopt=Citation>

APA

Heimpel, H., Anselstetter, V., Chrobak, L., Denecke, J., Einsiedler, B., Gallmeier, K., Griesshammer, A., Marquardt, T., Janka-Schaub, G., Kron, M., & Kohne, E. (2003). Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. BLOOD, 102(13), 4576-4581. [13]. http://www.ncbi.nlm.nih.gov/pubmed/12933587?dopt=Citation

Vancouver

Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. BLOOD. 2003;102(13):4576-4581. 13.

Bibtex

@article{3a4a6eacfa254f499dbbf1c11f11bd71,
title = "Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.",
abstract = "Congenital dyserythropoietic anemia type II (CDA II) is the most frequent type of congenital dyserythropoietic anemia. More than 200 cases have been described, but with the exception of a report by the International CDA II Registry, these reports include only small numbers of cases and no data on the lifetime evolution of the disease. Since 1967, we were able to follow 48 cases of CDA II from 43 families for up to 35 years. All patients exhibit chronic anemia of variable severity requiring regular red cell transfusions only in a minority of children; 60% developed gallstones before the age of 30 years, and 16 patients had cholecystectomy between 8 and 34 years of age. Iron overload was a frequent complication. In 16 cases, iron depletion started between 7 and 36 years. Three patients died from secondary hemochromatosis. Splenectomy, performed in 22 cases, led to moderate increases in hemoglobin values and eliminated the need for transfusions but did not prevent further iron loading. The current recommendation is to consider splenectomy if the anemia compromises patients' performance, and to manage iron overload according to the guidelines derived from patients with thalassemia.",
author = "Hermann Heimpel and Volker Anselstetter and Ladislav Chrobak and Jonas Denecke and Beate Einsiedler and Kerstin Gallmeier and Antje Griesshammer and Thorsten Marquardt and Gritta Janka-Schaub and Martina Kron and Elisabeth Kohne",
year = "2003",
language = "Deutsch",
volume = "102",
pages = "4576--4581",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

RIS

TY - JOUR

T1 - Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.

AU - Heimpel, Hermann

AU - Anselstetter, Volker

AU - Chrobak, Ladislav

AU - Denecke, Jonas

AU - Einsiedler, Beate

AU - Gallmeier, Kerstin

AU - Griesshammer, Antje

AU - Marquardt, Thorsten

AU - Janka-Schaub, Gritta

AU - Kron, Martina

AU - Kohne, Elisabeth

PY - 2003

Y1 - 2003

N2 - Congenital dyserythropoietic anemia type II (CDA II) is the most frequent type of congenital dyserythropoietic anemia. More than 200 cases have been described, but with the exception of a report by the International CDA II Registry, these reports include only small numbers of cases and no data on the lifetime evolution of the disease. Since 1967, we were able to follow 48 cases of CDA II from 43 families for up to 35 years. All patients exhibit chronic anemia of variable severity requiring regular red cell transfusions only in a minority of children; 60% developed gallstones before the age of 30 years, and 16 patients had cholecystectomy between 8 and 34 years of age. Iron overload was a frequent complication. In 16 cases, iron depletion started between 7 and 36 years. Three patients died from secondary hemochromatosis. Splenectomy, performed in 22 cases, led to moderate increases in hemoglobin values and eliminated the need for transfusions but did not prevent further iron loading. The current recommendation is to consider splenectomy if the anemia compromises patients' performance, and to manage iron overload according to the guidelines derived from patients with thalassemia.

AB - Congenital dyserythropoietic anemia type II (CDA II) is the most frequent type of congenital dyserythropoietic anemia. More than 200 cases have been described, but with the exception of a report by the International CDA II Registry, these reports include only small numbers of cases and no data on the lifetime evolution of the disease. Since 1967, we were able to follow 48 cases of CDA II from 43 families for up to 35 years. All patients exhibit chronic anemia of variable severity requiring regular red cell transfusions only in a minority of children; 60% developed gallstones before the age of 30 years, and 16 patients had cholecystectomy between 8 and 34 years of age. Iron overload was a frequent complication. In 16 cases, iron depletion started between 7 and 36 years. Three patients died from secondary hemochromatosis. Splenectomy, performed in 22 cases, led to moderate increases in hemoglobin values and eliminated the need for transfusions but did not prevent further iron loading. The current recommendation is to consider splenectomy if the anemia compromises patients' performance, and to manage iron overload according to the guidelines derived from patients with thalassemia.

M3 - SCORING: Zeitschriftenaufsatz

VL - 102

SP - 4576

EP - 4581

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 13

M1 - 13

ER -